Meeting
2012 ASCO Annual Meeting
Reproducibility, performance, and clinical utility of a genetic risk prediction model for prostate cancer in Japanese patients.
Authors
Shusuke Akamatsu
Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan
Shusuke Akamatsu , Ryo Takata , Atsushi Takahashi , Takahiro Inoue , Michiaki Kubo , Naoyuki Kamatani , Johji Inazawa , Tomoaki Fujioka , Tomonori Habuchi , Osamu Ogawa , Yusuke Nakamura , Hidewaki Nakagawa
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Genomic and Epigenomic Biomarkers
Citation
J Clin Oncol 30, 2012 (suppl; abstr 10520)
DOI
10.1200/jco.2012.30.15_suppl.10520
Abstract #
10520
Poster Bd #
13
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
A novel blood-based mRNA genomic test for screening, early detection, prognosis, and monitoring of prostate cancer: A multicenter study.
First Author: Yutaka Hashimoto
Poster
2023 ASCO Genitourinary Cancers Symposium
The impact of genomic biomarkers on a validated clinical risk prediction model for upgrading/upstaging among men with low-risk prostate cancer.
First Author: Avery Braun
Poster
2020 ASCO Virtual Scientific Program
A blood-based multi-mRNA liquid biopsy with >90% accuracy for diagnosis and assessment of prostate cancers.
First Author: Kambiz Rahbar
Poster
2020 Genitourinary Cancers Symposium
Clinical utility of biomarkers 4K score, SelectMDx and ExoDx with MRI for the detection of high-grade prostate cancer.
First Author: Vittorio Fasulo